← Back to Clinical Trials
Recruiting NCT07643064

NCT07643064 Clinical Efficacy of a Multicomponent Exercise and Comprehensive Geriatric Assessment Program (FRAIL+AP) in Frail Older Adults Within Primary Care: A Randomized Controlled Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07643064
Status Recruiting
Phase
Sponsor Universidad Europea de Madrid
Condition Frail Elderly
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2026-05-28
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 70 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
FRAIL+AP ProgramUsual Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2026-05-28 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Frailty is a multidimensional clinical syndrome associated with increased vulnerability to adverse health outcomes in older adults. Despite strong evidence supporting multicomponent exercise interventions, their implementation in primary care settings remains limited. This randomized controlled trial aims to evaluate the efficacy of the FRAIL+AP program, which integrates Comprehensive Geriatric Assessment (CGA) with a 12-week multicomponent exercise intervention, including visual-spatial gait retraining using the Tapiz Fisior system. The study will assess whether this intervention improves frailty status, physical performance, and functional independence, while reducing falls among community-dwelling older adults compared to standard care.

Eligibility Criteria

Inclusion Criteria: * Community-dwelling adults aged 70 years or older. * Ability and willingness to provide written informed consent. * Medical clearance to participate in low-to-moderate intensity physical exercise. * Presence of frailty or pre-frailty defined by meeting at least two of the following criteria: * Functional independence sufficient to participate in the intervention (Barthel Index \>80. * FRAIL Scale score ≥ 1. * Short Physical Performance Battery (SPPB) score \< 10. * Gait speed \< 0.8 m/s. * Timed Up and Go (TUG) test \> 12 seconds. * Registered at one of the participating primary care centers. Exclusion Criteria: * Absolute contraindications to physical exercise, including recent acute myocardial infarction, unstable angina, severe uncontrolled cardiovascular disease, or severe uncorrected aortic stenosis. * Severe cognitive impairment preventing comprehension of study procedures or exercise instructions. * Severe psychiatric disorders interfering with participation. * Absence of a legally authorized representative when required. * Severe uncontrolled behavioral disturbances. * Any acute or chronic medical condition considered by the investigators to make participation unsafe. Discontinuation Criteria: * Failure to attend the initial mandatory health education workshop. * Attendance at fewer than 6 of the 12 scheduled supervised exercise sessions. * Development of an acute medical condition that results in a temporary or permanent contraindication to physical activity. * Participant withdrawal of informed consent.

Contact & Investigator

Central Contact

Ángel Moisés Reyes Abreu, Registered Nurse

✉ enf.enlacetacoronte@gmail.com

📞 +34922474058

Principal Investigator

Ángel Moisés Reyes Abreu, Registered Nurse

PRINCIPAL INVESTIGATOR

Centro médico Tacoronte. Adress: Carr. Gral. del Nte., 5, 38350 Tacoronte, Santa Cruz de Tenerife

Frequently Asked Questions

Who can join the NCT07643064 clinical trial?

This trial is open to participants of all sexes, aged 70 Years or older, studying Frail Elderly. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07643064 currently recruiting?

Yes, NCT07643064 is actively recruiting participants. Contact the research team at enf.enlacetacoronte@gmail.com for enrollment information.

Where is the NCT07643064 trial being conducted?

This trial is being conducted at Tacoronte, Spain.

Who is sponsoring the NCT07643064 clinical trial?

NCT07643064 is sponsored by Universidad Europea de Madrid. The principal investigator is Ángel Moisés Reyes Abreu, Registered Nurse at Centro médico Tacoronte. Adress: Carr. Gral. del Nte., 5, 38350 Tacoronte, Santa Cruz de Tenerife. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology